St. Jude Medical, Inc.

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of its ILUMIEN™ OPTIS™ PCI Optimization System™, a new technology designed to ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its Board of Directors declared a second quarter dividend of $0.25 per common share. This ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval and European launch of its Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker (CRT-P). This ... read more

St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the first quarter ended March 30, 2013. First ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced publication of results from its landmark RESPECT trial in The New England Journal of Medicine. The ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of its ILUMIEN™ OPTIS™ System, a next-generation technology designed to help physicians make ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the first patient implant in a new pivotal trial evaluating the company’s AMPLATZER™ ... read more

St. Jude Medical, Inc. (NYSE:STJ) will present at the Barclays Global Healthcare Conference on Tuesday, March 12, in Miami. John Heinmiller, executive vice president, will address the conference ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the presentation of additional data from its landmark RESPECT trial at the American Stroke Association’s International ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the first patient implant of its 25 mm Portico™ Transcatheter Aortic Heart Valve using the Transfemoral ... read more

St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the fourth quarter and year ended December 29, 2012. ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced European CE Mark approval of its AMPLATZER™ Amulet™ Left Atrial Appendage Occluder. The Amulet device is ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of the next-generation Merlin.net™ Patient Care Network (PCN), a ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced preliminary revenue results for the fourth quarter ended Dec. 29, 2012. These results will be referenced ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the first patient enrollment in its ILUMIEN I clinical study. This observational study is designed to ... read more

St. Jude Medical, Inc. (NYSE:STJ) announced today that its Board of Directors has authorized a share repurchase of up to $1 billion of its outstanding common stock. The ... read more